Weedmaps parent WM Technology reported lower revenue and a quarterly loss on November 9, offering a view of pressure on the businesses that help cannabis retailers reach customers. The results connect the shopping experience on a cannabis marketplace with a less visible concern: whether its business clients can keep paying for their presence there.

The company’s third-quarter announcement covers the period ended September 30, 2026. Revenue was $38.5 million, compared with $42.2 million a year earlier, and consolidated net loss was $5.9 million, versus net income of $3.6 million. Management attributed much of the revenue pressure to client payment difficulties.

The client count measures businesses, not shoppers

Average monthly paying clients declined to 4,899 from 5,221. Average monthly revenue per paying client was $2,618, compared with $2,693 a year earlier. Those figures describe the company’s paying business relationships; they are not a count of people browsing cannabis menus or the amount a shopper spends on flower.

That distinction matters because a marketplace serves more than one audience. The consumer may experience it as a place to discover products, compare listings or find a retailer. The paying business evaluates a different transaction: whether the service is worth its advertising or commerce budget.

A decline in paying clients therefore cannot, by itself, establish that consumer interest in cannabis fell by the same amount. Likewise, a rise in browsing activity would not automatically prove that business customers are profitable or able to pay their bills. These measures answer different questions.

California remains a major part of the picture

The quarterly filing says approximately 61% of revenue came from California in both the three-month and nine-month periods ended September 30. The corresponding share was approximately 56% a year earlier. Substantially all revenue was generated in the United States.

Geographic concentration is useful context when reading a national-sounding cannabis technology story. Results from a platform with a large exposure to one state should not be treated as a complete survey of every legal market. Different customer mixes can produce different outcomes even within the same industry.

The filing also describes the composition of nine-month revenue: Featured Listings and WM Deal products represented approximately 63%, Standard Listings 31% and other advertising solutions 6%. These are revenue categories, not measures of how much shelf space a dispensary devotes to particular products.

For an operator evaluating marketing, that breakdown suggests a useful question: what exactly is being purchased and measured? A listing, a promotional placement and a completed retail sale are different steps. Assessing them together requires evidence about the business’s own results, rather than assuming visibility automatically equals revenue.

A positive adjusted figure does not erase a loss

WM Technology reported adjusted EBITDA of approximately $0.8 million, down from $7.6 million. Adjusted EBITDA is a non-GAAP measure, with the company’s reconciliation showing adjustments beyond ordinary net income. It should be read alongside the loss, rather than presented as an interchangeable description of profitability.

There is another distinction within the reported loss itself. The consolidated figure was $5.9 million, while the amount attributable to WM Technology was approximately $4.2 million after the non-controlling-interest allocation. A headline using either number needs to identify what it measures.

For readers who do not follow earnings reports, the important point is consistency. Compare like periods and like measures. A quarterly result should not be compared casually with a nine-month total, and an adjusted measure should not be set against a prior-year net-income figure as though the labels do not matter.

The outlook is still an estimate

As of the announcement, management expected fourth-quarter revenue to decline by a low-single-digit percentage from the third quarter. It also described a planned sponsored advertising product for brands. These are forward-looking statements, not completed fourth-quarter results or proof that a new product has already generated revenue.

The next meaningful test is whether later reporting supports those expectations. A strategy can be coherent without its outcome being established. Readers should keep the reported quarter, management’s explanation and its forecast separate when judging the announcement.

Our report on Missouri’s interstate cannabis guidance concerns a different issue, but highlights why the industry cannot be understood as a single unrestricted national market. For cannabis businesses, location and operating rules remain part of the commercial context.

WM Technology’s quarter shows pressure on the business side of cannabis discovery. The useful takeaway is not a prediction about its share price or the whole industry’s direction. It is a clearer view of the measures behind a familiar marketplace: paying clients, advertising revenue, geographic exposure and the difference between current results and future plans.

Illustrative business workspace photograph; not WM Technology offices or its software. Photo: Jakub Żerdzicki / Unsplash.

Missouri cannabis businesses have a clear message from state regulators: federal medical marijuana changes do not open the state’s borders to cannabis shipments. The Division of Cannabis Regulation says its existing system still controls what licensees may bring in, send out and do inside their facilities.

The warning appears in guidance dated November 2 and drew fresh attention in Tom Angell’s November 9 reporting for Marijuana Moment. For an industry watching federal reform closely, it is a practical reminder that a federal development and an operational permission are separate questions.

Two regulatory layers, not one replacement

The state describes federal registration as an additional layer alongside Missouri’s medical cannabis framework. Maintaining state licensure remains central. Its guidance directs licensees to continue complying with state requirements rather than treating participation in a federal process as a substitute for them.

That distinction matters because the word rescheduling can carry several different expectations in public conversation. People may use it to discuss federal classification, business registration, tax treatment or a possible future market. A change concerning one subject does not automatically resolve all the others.

Here, the state’s immediate concern is specific: current Missouri rules do not provide an import, export or interstate transport framework for regulated cannabis. Businesses should not read the guidance as announcing a new route for moving inventory across state lines. It says the necessary state arrangements are not yet in place.

What crossing the border would mean

Missouri distinguishes cannabis leaving its authorized system from outside product entering that system without authorization. The guidance describes these as diversion and inversion, respectively. The terms explain why the issue is larger than whether a vehicle can physically carry a package from one place to another.

A regulated supply chain needs a way to establish where a product originated, how it was tracked and which standards apply. An anticipated future permission cannot fill a present gap in that chain. That is why a commercial agreement, a prospective customer or a federal registration should not be treated as a complete shipping authorization.

For readers following cannabis business expansion, the distinction helps separate three milestones: a company’s intention to serve another market, a regulator’s permission to do so and the actual start of authorized shipments. An announcement about the first does not establish the second or third.

Daily compliance continues inside the facility

The guidance also preserves state product tracking, laboratory testing and visitor-access requirements. It says federal agents conducting legitimate official visits must present credentials, with facilities continuing to apply Missouri’s check-in, escort and security procedures.

That combination is more informative than suggesting a federal visit makes the state system disappear. The state is describing how official activity fits within existing facility controls. It is not instructing businesses to ignore federal officials or abandon the procedures governing access to restricted areas.

For an operator, the practical organizational challenge is keeping different teams aligned. Shipping staff, compliance staff and managers need the same understanding of what is currently authorized. A broad headline about reform is less useful at an inventory desk than a clear, current procedure tied to the relevant regulator.

Watch the next document, not the assumption

Missouri says it will issue further guidance if rules and infrastructure are updated to accommodate applicable federal changes. That makes a future state notice an important checkpoint. The present document does not establish a date on which interstate cannabis trade will begin.

Our coverage of federal medical cannabis registrations addressed another part of this developing framework. The Missouri notice adds a state-level boundary: progress in a federal process should be read alongside the rules governing the particular state market.

This does not make planning pointless. It changes how planning should be described. A business can prepare questions about future requirements without announcing that a currently prohibited activity has become available. Readers assessing a company’s expansion claims can ask which permissions are already effective and which remain contingent.

The same care applies to consumer expectations. News about potential supply-chain changes is not evidence that a particular out-of-state product is now available through Missouri’s regulated stores. Availability and authorization need their own verification, rather than being inferred from a national headline.

The current message is operationally conservative and commercially significant: keep regulated Missouri cannabis within the authorized system, continue existing compliance routines and wait for an actual state framework before treating interstate trade as an active business option.

There is also a near-term information-management issue. The guidance flags new confidentiality provisions in HB 2641 taking effect November 11. Businesses handling requests for records should distinguish that question from permission to move product. Both belong to compliance planning, but neither is answered merely by saying that an organization has entered the federal registration process.

Illustrative U.S. road scene; not cannabis transport or a Missouri facility. Photo: Ben Zelenka / Unsplash.

Village Farms International reported record cannabis sales on November 9, with international shipments helping its latest quarter while cannabis profit measures moved lower than a year earlier. The combination makes this a more revealing earnings report than a record-sales headline alone suggests: growth in one part of a cannabis business can coexist with tighter margins.

The company’s third-quarter release covers the three months ended September 30, 2026. Figures below are in U.S. dollars unless otherwise identified. These are reported operating results and management expectations, not a prediction of the company’s share price.

Cannabis sales rise, margins retreat

Village Farms reported cannabis sales of $55 million, up 3% from approximately $53.5 million a year earlier. International cannabis exports reached $20.8 million, increasing 75% year over year and remaining roughly level with the preceding quarter’s record. The export business was a prominent contributor to the growth story.

But cannabis gross margin declined to 48% from 55%. Cannabis net income fell to $7.8 million from $12 million, while adjusted EBITDA from continuing cannabis operations declined to $14.7 million from $20.2 million. The company cited softer Canadian wholesale spot pricing among the factors affecting profitability.

Those figures describe different layers of the same operation. Sales show the value of business booked. Gross margin indicates how much remains after the costs included at that stage of the accounts. Net income and an adjusted operating measure then answer further questions. A record at the top of the statement does not require a record farther down.

The group is larger than its cannabis segment

Consolidated quarterly sales were $66.9 million, compared with $66.7 million a year earlier. The company’s quarterly SEC filing reports net income attributable to shareholders of about $10 million, versus $10.2 million in the comparable quarter. Those group totals should not be substituted for the cannabis figures.

Village Farms’ operations include Canadian cannabis businesses, a U.S. CBD business, Netherlands cannabis activities and produce operations. Readers evaluating a headline about its overall performance therefore need to ask which segment produced the change. The group total and a cannabis-only comparison are useful together precisely because they have different boundaries.

That is also why adjusted EBITDA should retain its full label. It is a company-reported adjusted measure, not interchangeable with net income or money left in a bank account. When comparing cannabis businesses, start with matching periods and definitions before deciding that a larger number represents stronger underlying performance.

Quarterly cash and the longer view

The release reports $9.5 million in consolidated operating cash flow for the quarter. The filing’s nine-month statement tells a separate, longer-period story: operating cash from continuing operations was approximately $1.6 million, compared with $46.7 million in the prior-year nine-month period. Working-capital movements were a major difference in that comparison.

These figures do not contradict each other. A strong quarter can arrive after earlier cash demands, and a nine-month total incorporates all three quarters. Mixing the two periods would obscure rather than explain the business. The filing also reports about $17.3 million of capital expenditures over nine months, up from $7.1 million.

For anyone following the sector’s expansion, that creates a practical reading order: examine the quarter, then step back to the year-to-date statement, and then consider investment spending separately. The question is how the operation funds its plans over time, rather than whether one isolated cash figure looks attractive.

Expansion remains a forward-looking story

Management described the Netherlands’ second phase as fully planted and outlined further Canadian capacity work. Its Delta 2 expansion is expected to finish in the first quarter of 2027 and reach full capacity around midyear. These are expectations about future operations, which should remain clearly separated from production already achieved.

That separation is particularly important in cannabis, where a facility plan, a planted crop, a shipment and recognized revenue mark different stages. An announced expansion can establish the direction of a strategy without establishing when all of its financial contribution will appear.

Our earlier report on Cresco’s latest quarter offers another example of why sales, losses and cash flow deserve separate attention. Village Farms adds an international dimension to that conversation, alongside a clear reminder that export growth and margin pressure can appear in the same report.

The next useful checkpoint is execution: whether the outlined capacity milestones arrive, how international demand translates into shipments, and whether improved sales ultimately support profitability and cash generation. Monday’s results establish the starting figures for that assessment; they do not settle the outcome in advance.

For industry readers, the most useful comparison in the next report will use the same definitions again. Track cannabis revenue against cannabis margins, consolidated cash against consolidated cash, and completed investment against the timetable management has described. That consistent approach leaves room for both the encouraging export figures and the pressures elsewhere in the accounts, without selecting only the numbers that support a preferred narrative.

Illustrative cannabis cultivation stock photo; not a Village Farms facility. Photo: Evan Strock / Unsplash.